Home > News > Targeting Nanoparticles to Leukemia Cells and T-Lymphocytes
June 1st, 2005
Targeting Nanoparticles to Leukemia Cells and T-Lymphocytes
Abstract:
Investigators in Germany have developed a method for creating antibody-labeled gelatin nanoparticles that can target specific cells and then dissolve upon uptake by those cells, raising the possibility that gelatin nanoparticles could serve as biodegradable drug delivery vehicles. Reporting its work in the journal Biomaterials, a research team led by Hagen von Briesen, Ph.D., of the Fraunhofer Institute for Biomedical Engineering in St. Ingbert, Germany, showed that crosslinked gelatin nanoparticles could be readily labeled with an antibody that binds to the cell-surface protein CD3. This protein is found on the surface of certain types of leukemic T-lymphocytes.
Source:
NCI
Bookmark:
| Related Links |
Fraunhofer Institute for Biomedical Engineering
| Related News Press |
Possible Futures
Researchers at the Catalan Institute of Nanoscience and Nanotechnology show that bending semiconductors generates electricity September 26th, 2016
Chains of nanogold – forged with atomic precision September 23rd, 2016
Tattoo therapy could ease chronic disease: Rice-made nanoparticles tested at Baylor College of Medicine may help control autoimmune diseases September 23rd, 2016
Nanomedicine
Fighting cancer with sticky nanoparticles September 27th, 2016
Gold nanoparticles conjugated quercetin inhibits epithelial-mesenchymal transition, angiogenesis and invasiveness via EGFR/VEGFR-2 mediated pathway in breast cancer September 27th, 2016
Tattoo therapy could ease chronic disease: Rice-made nanoparticles tested at Baylor College of Medicine may help control autoimmune diseases September 23rd, 2016
BBI Solutions launches innovative conjugate blocking technology that enhances signal intensity for lateral flow immunoassays September 20th, 2016
Announcements
Picosun patents ALD nanolaminate to prevent electronics from overheating September 28th, 2016
Leti and Taiwanese Tech Organizations Sponsoring Workshop in Taipei on MEMS, IoT, Smart Lighting Applications, System Reliability & Security September 28th, 2016
Fighting cancer with sticky nanoparticles September 27th, 2016
Gold nanoparticles conjugated quercetin inhibits epithelial-mesenchymal transition, angiogenesis and invasiveness via EGFR/VEGFR-2 mediated pathway in breast cancer September 27th, 2016
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
University Technology Transfer & Patents
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||
